BNT162b2 mRNA COVID-19 Vaccine Effectiveness in the Prevention of SARS-CoV-2 Infection and Symptomatic Disease in Five-Month Follow-Up: A Retrospective Cohort StudyArticle Published on 2021-10-072022-10-28 Journal: Vaccines [Category] COVID-19, [키워드] BNT162b2 mRNA COVID-19 COVID-19 pandemic COVID-19 vaccine documented infection Effectiveness evaluated first dose General population greater HCW HCWs healthcare worker Healthcare workers immunize Infection initiated Italian Italy mandatory medium prevention SARS-CoV-2 SARS-COV-2 infection second dose symptomatic disease the vaccine two group vaccination vaccination rate vaccination schedule Vaccine vaccine effectiveness [DOI] 10.3390/vaccines9101143 PMC 바로가기 [Article Type] Article
Direct and Indirect Effectiveness of mRNA Vaccination against Severe Acute Respiratory Syndrome Coronavirus 2 in Long-Term Care Facilities, SpainResearch Published on 2021-10-012022-10-31 Journal: Emerging Infectious Diseases [Category] COVID-19, MERS, SARS, [키워드] 95% CI acute respiratory syndrome adjusted age BNT162b2 Care cohort study conducted coronavirus coronavirus 2 coronavirus disease COVID-19 Direct dose doses Effectiveness elderly incidence indirect effects Infection long-term care facilities mRNA offered Pfizer/BioNTech prevented Reproduction number respiratory respiratory infections risk SARS-CoV-2 selected severe acute respiratory syndrome coronavirus 2 Spain Transmissibility vaccination Vaccine vaccine effectiveness viruses zoonoses [DOI] 10.3201/eid2710.211184 PMC 바로가기 [Article Type] Research
Effectiveness of Pneumococcal Conjugate Vaccines Against Community-acquired Alveolar Pneumonia Attributable to Vaccine-serotype Streptococcus pneumoniae Among Children백신 혈청형 폐렴구균에 기인한 지역사회 획득 폐렴에 대한 폐렴구균 결합 백신의 효과성 어린이 대상Article Published on 2021-10-012024-07-30 Journal: Clinical infectious diseases : an official publication of the Infectious [Category] 폐렴구균 감염증, [키워드] pediatric pneumococcal conjugate vaccine Pneumonia Streptococcus pneumoniae vaccine effectiveness [DOI] 10.1093/cid/ciaa1860 PMC 바로가기
Effectiveness of Influenza Vaccines in the HIVE Household Cohort Over 8 Years: Is There Evidence of Indirect Protection?Article Published on 2021-10-012023-06-14 Journal: Clinical Infectious Diseases: An Official Publicat [Category] Fulltext, 신종인플루엔자, [키워드] cohort study indirect protection Influenza vaccine effectiveness [DOI] 10.1093/cid/ciab395 PMC 바로가기
Product-specific COVID-19 vaccine effectiveness against secondary infection in close contacts, Navarre, Spain, April to August 2021Rapid Communication Published on 2021-09-302022-10-31 Journal: Eurosurveillance [Category] COVID-19, SARS, [키워드] by product close contact cohort study COVID-19 COVID-19 vaccine dose effective Effectiveness hospitalisation Infection infection control janssen ranged SARS-CoV-2 Spain Vaccine vaccine effectiveness [DOI] 10.2807/1560-7917.ES.2021.26.39.2100894 PMC 바로가기 [Article Type] Rapid Communication
High level of protection against COVID-19 after two doses of BNT162b2 vaccine in the working age population – first results from a cohort study in Southern SwedenResearch Article Published on 2021-09-292022-10-30 Journal: Infectious diseases (London, England) [Category] COVID-19, COVID19(2023년), MERS, SARS, [키워드] 95% CI age Analysis BNT162b2 vaccine cohort study Community COVID-19 COVID-19 testing COVID-19 vaccines dose Effectiveness female Infection males of BNT162b2 Positive test preventing infection Result SARS-CoV2 second dose Sex single dose Spread stratified suggested the disease Vaccine vaccine effectiveness [DOI] 10.1080/23744235.2021.1982144 PMC 바로가기 [Article Type] Research Article
mRNA vaccine effectiveness against COVID-19-related hospitalisations and deaths in older adults: a cohort study based on data linkage of national health registries in Portugal, February to August 2021Rapid Communication Published on 2021-09-232022-10-31 Journal: Eurosurveillance [Category] COVID-19, SARS, [키워드] 95% confidence interval Adults age cohort study COVID-19 related death death dose Effectiveness Evidence groups Health hospitalisation Mortality mRNA vaccine National Older Older adults Portugal SARS-CoV-2 vaccine effectiveness was measured [DOI] 10.2807/1560-7917.ES.2021.26.38.2100833 PMC 바로가기 [Article Type] Rapid Communication
Shooting at a Moving Target—Effectiveness and Emerging Challenges for SARS-CoV-2 Vaccine DevelopmentReview Published on 2021-09-222022-10-28 Journal: Vaccines [Category] COVID-19, [키워드] accelerate addressed adverse effects applied approval Breakthrough infection challenge clinical evaluation Compliance COVID-19 development Effectiveness Healthcare systems heterologous vaccination highlight Immune escape immunization implementation IMPROVE infected individual Infection Isolation Long COVID Mask measure mRNA vaccine normality Occurrence pandemic pathway positive powerful tool Prevent PROTECT restrict Safe SARS-CoV-2 SARS-CoV-2 pandemic SARS-CoV-2 vaccine SARS-CoV-2 vaccines second generation vaccines severe COVID-19 Shooting Side effect social distancing Transmission Vaccination strategy Vaccine Vaccine development vaccine effectiveness vaccine safety Vaccines variants Variation Viral antigen virus transmission virus variant virus variants [DOI] 10.3390/vaccines9101052 PMC 바로가기 [Article Type] Review
Prospective Cohort Study of the Kinetics of Specific Antibodies to SARS-CoV-2 Infection and to Four SARS-CoV-2 Vaccines Available in Serbia, and Vaccine Effectiveness: A 3-Month Interim ReportArticle Published on 2021-09-172022-10-28 Journal: Vaccines [Category] COVID-19, [키워드] antibody antibody level AstraZeneca BBIBP-CorV BNT-162b2 ChAdOx1-S COVID-19 cut-off dose eight elicited first dose Gam-COVID-Vac Hospitalization individual Infection Interim Kinetics levels of antibody naïve individuals occurred Post-infection Prospective Receptor binding domain recipient recipients remained report required SARS-CoV-2 SARS-COV-2 infection seronegative Sinopharm Specific specific antibodies specific antibody specific IgG antibody spike protein RBD the SARS-CoV-2 vaccination Vaccine vaccine dose vaccine effectiveness Vaccines [DOI] 10.3390/vaccines9091031 PMC 바로가기 [Article Type] Article
Recombinant Zoster Vaccine (Shingrix): Real-World Effectiveness in the First 2 Years Post-Licensure재조합 대상포진 백신 (Shingrix): 허가 후 첫 2년간의 실제 효과성Observational Study Published on 2021-09-152023-06-01 Journal: Clinical Infectious Diseases: An Official Publicat [Category] 대상포진, 두창, 수두, 홍역, [키워드] herpes zoster vaccine Medicare Real-world evidence shingrix vaccine vaccine effectiveness [DOI] 10.1093/cid/ciab125 [Article Type] Observational Study